Stockreport

GoodRx Reveals Americans Overspent on Weight Loss Medications by $200 Million This Year, Fills Still Surged

GoodRx Holdings, Inc. - Class A  (GDRX) 
PDF In 2024, fills for Wegovy and Zepbound increased by over 100% and 300%, respectively SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading prescri [Read more]